DIAGNOSTICS OF ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE CARDIAC ELECTRONIC DEVICES: PREVALENCE AND RISK FACTORS

Aim. To evaluate the prevalence and to search for the risk factors of atrial fibrillation (AF) development in patients with implantable cardiac electronic devices (dualchamber stimulators (ECS), implantable cardioverter-defibrillators and resynchronizers).Material and methods. The design of the stud...

Full description

Bibliographic Details
Main Authors: Yu. S. Sazonova, D. A. Andreev, I. V. Samoylenko, A. L. Syrkin, М. V. Serova, A. A. Bykova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2017-12-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1660
id doaj-2b85c721a5004698b04c0885bec0d440
record_format Article
spelling doaj-2b85c721a5004698b04c0885bec0d4402021-07-28T14:02:31Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202017-12-01012626710.15829/1560-4071-2017-12-62-672266DIAGNOSTICS OF ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE CARDIAC ELECTRONIC DEVICES: PREVALENCE AND RISK FACTORSYu. S. Sazonova0D. A. Andreev1I. V. Samoylenko2A. L. Syrkin3М. V. Serova4A. A. Bykova5I.M. Sechenov First Moscow State Medical University of the Ministry of Health; City Clinical Hospital № 4I.M. Sechenov First Moscow State Medical University of the Ministry of HealthI.M. Sechenov First Moscow State Medical University of the Ministry of Health; City Clinical Hospital № 4I.M. Sechenov First Moscow State Medical University of the Ministry of HealthI.M. Sechenov First Moscow State Medical University of the Ministry of HealthI.M. Sechenov First Moscow State Medical University of the Ministry of HealthAim. To evaluate the prevalence and to search for the risk factors of atrial fibrillation (AF) development in patients with implantable cardiac electronic devices (dualchamber stimulators (ECS), implantable cardioverter-defibrillators and resynchronizers).Material and methods. The design of the study is prospective single center, with consequent inclusion of 304 patients at the age ≥18 y.o. and with no documented AF in anamnesis, with indications for implantation of replacement of ECS. Patients followup lasted for 12-18 months with 1-3 months periodicity visits. In the analysis of data on rhythm disorders, stored in ECS memory, as significant the episodes of high cardiac rate with duration more 6 minutes per day and detection rate more than 175- 180 beats per minute were taken. Also, in all the patients clinical and demographic data was assessed, laboratory and echocardiography methods applied.Results. The study was completed in 224 patients, the rest were lost at different stages. AF was found in 57 (25,4%), and in 43 (75,4%) the episode were nonsymptomatic. In 3 months after implantation, AF revealing rate was 14,9% (38 patients of 255 at the 1st visit). Independent risk factors for AF were thromboembolic complications in anamnesis (HR 4,72; 95% CI 2,279-9,77; р<0,0001), increased left atrium volume index (HR 2,07; 95% CI 1,075-3,975; р=0,029), and hemoglobin level decrease (HR 2,58; 95% CI 1,245-5,35; р=0,011).Conclusion. The prevalence of AF in the patients with implantable cardiac devices is quite high. Most patients have their episodes asymptomatic. Most commonly, AF is found during 3 months from the operation. Risk factors for AF according to our data, were thromboembolic complications in anamnesis, increased left atrium volume index, and hemoglobin level decrease.https://russjcardiol.elpub.ru/jour/article/view/1660atrial fibrillationdual chamber pacemakerhigh cardiac rate episodes
collection DOAJ
language Russian
format Article
sources DOAJ
author Yu. S. Sazonova
D. A. Andreev
I. V. Samoylenko
A. L. Syrkin
М. V. Serova
A. A. Bykova
spellingShingle Yu. S. Sazonova
D. A. Andreev
I. V. Samoylenko
A. L. Syrkin
М. V. Serova
A. A. Bykova
DIAGNOSTICS OF ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE CARDIAC ELECTRONIC DEVICES: PREVALENCE AND RISK FACTORS
Российский кардиологический журнал
atrial fibrillation
dual chamber pacemaker
high cardiac rate episodes
author_facet Yu. S. Sazonova
D. A. Andreev
I. V. Samoylenko
A. L. Syrkin
М. V. Serova
A. A. Bykova
author_sort Yu. S. Sazonova
title DIAGNOSTICS OF ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE CARDIAC ELECTRONIC DEVICES: PREVALENCE AND RISK FACTORS
title_short DIAGNOSTICS OF ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE CARDIAC ELECTRONIC DEVICES: PREVALENCE AND RISK FACTORS
title_full DIAGNOSTICS OF ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE CARDIAC ELECTRONIC DEVICES: PREVALENCE AND RISK FACTORS
title_fullStr DIAGNOSTICS OF ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE CARDIAC ELECTRONIC DEVICES: PREVALENCE AND RISK FACTORS
title_full_unstemmed DIAGNOSTICS OF ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE CARDIAC ELECTRONIC DEVICES: PREVALENCE AND RISK FACTORS
title_sort diagnostics of atrial fibrillation in patients with implantable cardiac electronic devices: prevalence and risk factors
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2017-12-01
description Aim. To evaluate the prevalence and to search for the risk factors of atrial fibrillation (AF) development in patients with implantable cardiac electronic devices (dualchamber stimulators (ECS), implantable cardioverter-defibrillators and resynchronizers).Material and methods. The design of the study is prospective single center, with consequent inclusion of 304 patients at the age ≥18 y.o. and with no documented AF in anamnesis, with indications for implantation of replacement of ECS. Patients followup lasted for 12-18 months with 1-3 months periodicity visits. In the analysis of data on rhythm disorders, stored in ECS memory, as significant the episodes of high cardiac rate with duration more 6 minutes per day and detection rate more than 175- 180 beats per minute were taken. Also, in all the patients clinical and demographic data was assessed, laboratory and echocardiography methods applied.Results. The study was completed in 224 patients, the rest were lost at different stages. AF was found in 57 (25,4%), and in 43 (75,4%) the episode were nonsymptomatic. In 3 months after implantation, AF revealing rate was 14,9% (38 patients of 255 at the 1st visit). Independent risk factors for AF were thromboembolic complications in anamnesis (HR 4,72; 95% CI 2,279-9,77; р<0,0001), increased left atrium volume index (HR 2,07; 95% CI 1,075-3,975; р=0,029), and hemoglobin level decrease (HR 2,58; 95% CI 1,245-5,35; р=0,011).Conclusion. The prevalence of AF in the patients with implantable cardiac devices is quite high. Most patients have their episodes asymptomatic. Most commonly, AF is found during 3 months from the operation. Risk factors for AF according to our data, were thromboembolic complications in anamnesis, increased left atrium volume index, and hemoglobin level decrease.
topic atrial fibrillation
dual chamber pacemaker
high cardiac rate episodes
url https://russjcardiol.elpub.ru/jour/article/view/1660
work_keys_str_mv AT yussazonova diagnosticsofatrialfibrillationinpatientswithimplantablecardiacelectronicdevicesprevalenceandriskfactors
AT daandreev diagnosticsofatrialfibrillationinpatientswithimplantablecardiacelectronicdevicesprevalenceandriskfactors
AT ivsamoylenko diagnosticsofatrialfibrillationinpatientswithimplantablecardiacelectronicdevicesprevalenceandriskfactors
AT alsyrkin diagnosticsofatrialfibrillationinpatientswithimplantablecardiacelectronicdevicesprevalenceandriskfactors
AT mvserova diagnosticsofatrialfibrillationinpatientswithimplantablecardiacelectronicdevicesprevalenceandriskfactors
AT aabykova diagnosticsofatrialfibrillationinpatientswithimplantablecardiacelectronicdevicesprevalenceandriskfactors
_version_ 1721269098704273408